Skip to main content

brinzolamide/brimonidine tartrate 2 mg/mL / 10 mg/mL Medicare Part D Coverage

Brand name: SIMBRINZA
Dosage form
SUSPENSION/ DROPS
Route
OPHTHALMIC
82%
of Medicare Part D plans
cover brinzolamide/brimonidine tartrate
4,522 of 5,530 plans
3.5
Avg. formulary tier
$0.00
Median 30-day copay
$0.00–$0.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify brinzolamide/brimonidine tartrate. Lower tiers = lower copays.

Tier 1 - Preferred Generic 4%
161 plans • avg $0.00/mo
Tier 2 - Generic 0%
4 plans • avg $0.00/mo
Tier 3 - Preferred Brand 40%
1,802 plans • avg $3.18/mo
Tier 4 - Non-Preferred Drug 57%
2,555 plans • avg $2.33/mo

Find the cheapest plan for brinzolamide/brimonidine tartrate

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for brinzolamide/brimonidine tartrate →

Get brinzolamide/brimonidine tartrate Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

brinzolamide/brimonidine tartrate Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Frequently Asked Questions about brinzolamide/brimonidine tartrate

82% of Medicare Part D plans cover brinzolamide/brimonidine tartrate. It is most commonly placed on Tier 4. Coverage varies by plan and geographic area.

The median 30-day copay for brinzolamide/brimonidine tartrate on Medicare Part D is $0.00 at a preferred pharmacy. Costs range from $0.00 to $0.00 depending on the plan.

brinzolamide/brimonidine tartrate is placed on Tier 4 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for brinzolamide/brimonidine tartrate. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →